Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
Chesnut CH 3rd, Skag A, Christiansen C, Recker R, Stakkestad JA, Hoiseth A, Felsenberg D, Huss H, Gilbride J, Schimmer RC, Delmas PD; Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE).
Chesnut CH 3rd, et al. Among authors: schimmer rc.
J Bone Miner Res. 2004 Aug;19(8):1241-9. doi: 10.1359/JBMR.040325. Epub 2004 Mar 29.
J Bone Miner Res. 2004.
PMID: 15231010
Free article.
Clinical Trial.